Doctors and patients report on new hair loss drug
NCT ID NCT07200128
Summary
This study looked back at survey data from US dermatologists and their adult patients with severe alopecia areata, a condition causing significant hair loss. It aimed to understand the real-world experiences of patients taking a medication called ritlecitinib and their doctors' satisfaction with it. The research analyzed how patients' hair loss severity changed over time while on the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer
New York, New York, 10001, United States
Conditions
Explore the condition pages connected to this study.